Projects

ATPCI

SponsorInstitut de Recherches Internationales
Servier (I.R.I.S.)
Therapeutic AreaCardiovascular
Study TitleThe efficAcy and safety of
Trimetazidine in Patients with angina
pectoris having been treated by
percutaneous Coronary Intervention.
(ATPCI)
Study AcronymATPCI
Study TypeInterventional
CT PhasePhase III
Nº EudraCT2010-022134-89
Number of Countries27
Number of Sites
(Portugal)
8
Recruitment
target
  (Global)
5600
Recruitment
target
(Portugal)
80
Recruitment achived80 (100%)
National CoordinatorFausto Pinto, MD, PhD
StatusIn Close-out

COLCOT

SponsorMontreal Heart Institute
Therapeutic AreaCardiovascular
Study TitleCOLCHICINE CARDIOVASCULAR OUTCOMES TRIAL (COLCOT)
Study AcronymCOLCOT
Study TypeInterventional
CT PhasePhase III
Nº EudraCT2014-005172-28
Number of Countries12
Number of Sites
(Portugal)
6
Recruitment
target
  (Global)
4500
Recruitment
target
  (Portugal)
180
Recruitment
achieved
(Portugal)
227 (122%)
National
Coordinator
Fausto Pinto, MD, PhD
StatusIn Close-out

RESHAPE-HF2

SponsorUniversity Medical Center Göttingen (UMG)
Therapeutic AreaInterventional Cardiology
Study TitleA RandomizEd Study of tHe MitrACliP DEvice in Heart Failure Patients with Clinically Significant Functional Mitral Regurgitation (The RESHAPE-HF2 Trial)
Study AcronymRESHAPE-HF2
Study TypeInterventional (medical device)
CT PhaseNA
Nº EudraCTNA
Number of Countries9
Number of Sites
(Portugal)
3
Recruitment
target
  (Global)
380
Recruitment
target
(Portugal)
45
Recruitment achived (Portugal)Ongoing study
National CoordinatorNA
StatusRecruitment on hold

FAIR-HF2

SponsorUniversity Medical Center Hamburg-Eppendorf
Therapeutic AreaCardiovascular
Study TitleIntravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality – FAIR-HF2
Study AcronymFAIR-HF2
Study TypeInterventional
CT PhasePhase IV
Nº EudraCT2016-000068-40
Number of Countries6
Number of Sites
(Portugal)
2
Recruitment
target
  (Global)
1200
Recruitment
target
(Portugal)
30
Recruitment achived (Portugal)Ongoing study
National CoordinatorFausto Pinto, MD, PhD
StatusIn Recruitment

GO-VISION

SponsorInstituto de Medicine Molecular João Lobo Antunes (iMM)
FundingMERCK
Therapeutic AreaOphthalmology/Rheumathology
Study TitleProspective observational study to examine the change of vision-related quality of life in subjects with spondyloarthritis during treatment with monthly subcutaneous injections of golimumab 50 mg according to EU label (GO-VISION)
Study AcronymGO-VISION
Study TypeNon-interventional
CT PhaseNA
Nº EudraCTNA
Number of Countries1
Number of Sites
(Portugal)
8
Recruitment
target
  (Global)
30
Recruitment
target
(Portugal)
30
Recruitment achived (Portugal)Ongoing study
National CoordinatorInês Leal, MD, PhD
StatusIn Recruitment

BLITZ-AF Cancer

SponsorFoundazione per il Tuo cuore – HCF Onlus
Therapeutic AreaCardiology/Oncology
Study TitleMulticenter, non-interventional study on patients with atrial fibrillation (AF) and cancer (diagnosed within the last 3 years prior to enrolment)
Study AcronymBLITZ-AF Cancer
Study TypeNon-interventional
CT PhaseNA
Nº EudraCTNA
Number of Countries6
Number of Sites
(Portugal)
4
Recruitment
target
  (Global)
1500
Recruitment
target
(Portugal)
100
Recruitment achived (Portugal)Ongoing study
National CoordinatorFausto Pinto, MD, PhD
StatusIn Recruitment

SAFEST

SponsorAssociação para a Investigação e Desenvolvimento da Faculdade de Medicina – AIDFM
FundingDAIICHI SANKYO
Therapeutic AreaCardiovascular
Study TitleScreening of Atrial Fibrillation among Elderly in primary Care with MyDiagnoSTick
Study AcronymSAFEST
Study TypeNon-interventional
CT PhaseNA
Nº EudraCTNA
Number of Countries1
Number of Sites
(Portugal)
21 Primary Care Units
Recruitment
target
  (Global)
NA
Recruitment
target
(Portugal)
10.000
Recruitment achived (Portugal)Start-up
National CoordinatorRicardo Fontes Carvalho, MD, PhD
StatusStart-up

LITMUS

SponsorFaculdade de Medicina da Universidade de Lisboa
Therapeutic AreaGastroenterology
Study TitleLiver Investigation: Testing Marker Utility in Steatohepatitits
Study AcronymLITMUS
Study TypeNon-interventional
CT PhaseNA
Nº EudraCTNA
Number of Countries13
Number of Sites
(Portugal)
1
Recruitment
target
  (Global)
5000
Recruitment
target
(Portugal)
50
Recruitment achived (Portugal)Ongoing study
National CoordinatorHelena Cortez-Pinto, MD, PhD
StatusIn Recruitment

SVA

SponsorAssociação para a Investigação e Desenvolvimento da Faculdade de Medicina – AIDFM
Therapeutic AreaCardiology
Study TitleCharacterization of the inflammatory response in patients submitted to surgical replacement of aortic valve
Study AcronymSVA
Study TypeNon-interventional
CT PhaseNA
Nº EudraCTNA
Number of Countries1
Number of Sites
(Portugal)
6
Recruitment
target
  (Global)
NA
Recruitment
target
(Portugal)
120
Recruitment achived (Portugal)Ongoing study
National CoordinatorNA
StatusIn Recruitment

TREOCAPA

SponsorThe French National Institute for Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, “Inserm”)
Therapeutic AreaPaediatrics/Cardiology
Study TitleProphylactic treatment of the ductus arteriosus in preterm infants by acetaminophen
Study AcronymTREOCAPA
Study TypeInterventional
CT PhasePhase II/III
Nº EudraCT2019-004297-26
Number of Countries17
Number of Sites
(Portugal)
3
Recruitment
target
  (Global)
824
Recruitment
target
(Portugal)
21
Recruitment achived (Portugal)Ongoing study
National CoordinatorAndré Graça, MD, PhD
StatusStart-up

CL2-62798-010

SponsorInstitut de Recherches Internationales Servier (I.R.I.S.)
Therapeutic AreaCardiovascular
Study TitleA Multicentre, Randomized, Double-blind, Placebo-controlled Dose-finding Study of S62798 in Patients with Intermediate-High Risk Acute Pulmonary Embolism on heparin
Study AcronymCL2-62798-010
Study TypeInterventional
CT PhasePhase II
Nº EudraCT2019-003514-14
Number of Countries20
Number of Sites
(Portugal)
4
Recruitment
target
  (Global)
370
Recruitment
target
(Portugal)
12
Recruitment achived (Portugal)Ongoing study
National CoordinatorFausto Pinto, MD, PhD
StatusStar-up

LONSURF

SponsorInstitut de Recherches Internationales Servier (I.R.I.S.)
Therapeutic AreaOncology
Study TitleAn open-label early access phase IIIb study of trifluridine/tipiracil (S 95005/TAS-102) in patients with a pretreated metastatic colorectal cancer.
Study AcronymLONSURF
Study TypeInterventional
CT PhasePhase IIIb
Nº EudraCT2016-002311-18
Number of Countries20
Number of Sites
(Portugal)
6
Recruitment
target
  (Global)
1000
Recruitment
target
(Portugal)
24
Recruitment achived (Portugal)24 (100%)
National CoordinatorHélder Mansinho, MD
StatusClosed